Stay updated on Fasinumab Long-Term Safety in OA Clinical Trial
Sign up to get notified when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.

Latest updates to the Fasinumab Long-Term Safety in OA Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version without changes to the study details.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page's revision tag now reads v3.6.2, replacing the previous v3.6.0. This indicates a maintenance/version update to the page rather than a substantive data or content change.SummaryDifference0.0%

- Check29 days agoChange DetectedThe Study Details page adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment note ('No longer looking for participants'), and updates the Intervention/Treatment heading (Intervention / Treatment removed in favor of Intervention/Treatment) with a revision bump to v3.6.0.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, representing a small update to the study details page.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded a new PubMed publication to the Publications section: DiMartino SJ et al. on the prevalence of preexisting articular bone pathology in OA patients screened for fasinumab, published in Osteoarthritis Cartilage (2024). This expands the study's list of published related research.SummaryDifference0.0%

- Check58 days agoChange DetectedA new revision tag v3.5.4 has been added to the page metadata, and the previous revision tag v3.5.3 has been removed.SummaryDifference0.0%

Stay in the know with updates to Fasinumab Long-Term Safety in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fasinumab Long-Term Safety in OA Clinical Trial page.